Emergent BioSolutions Inc.

Emergent BioSolutions, a U.S. life‑sciences firm, markets a diversified portfolio of vaccines and therapeutics (NARCAN, Vaxchora, BioThrax, EBS‑Ebola) and offers contract R&D and manufacturing for government‑client solutions.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 900
HQ: Gaithersburg

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
EBS	Emergent BioSolutions Inc. Cap: 0.7B \| P/E: 10.0	EQUITY	NYQ	USD	US29089Q1058	Active	📈